Michelle Corcoran, NP
Nurse Practitioner · Yorba Linda, CANPI 1881802759
Payments from drug & device makers
Across 32 payments — averaging $25.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$290
- Idorsia Pharmaceuticals US Inc$138
- Novo Nordisk$89
- Lilly USA, LLC$81
- Boehringer Ingelheim$55
- GSK$53
- plus $107 from 4 others
What the payments were for
- Food & beverage$812100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $290 |
| Idorsia Pharmaceuticals US Inc | 2 | $138 |
| Novo Nordisk | 4 | $89 |
| Lilly USA, LLC | 5 | $81 |
| Boehringer Ingelheim | 3 | $55 |
| GSK | 3 | $53 |
| AbbVie | 3 | $53 |
| Eisai Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$812 in reported general payments places this provider in the 75th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $27,248 |
| Atorvastatin Calcium | 125 | $1,233 |
| Levothyroxine Sodium | 86 | $1,228 |
| Losartan Potassium | 84 | $1,021 |
| Omeprazole | 34 | $505 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $484 |
| Fluticasone Propionate | 36 | $483 |
| Metoprolol Succinate | 25 | $467 |
| Diclofenac Sodium | 17 | $422 |
| Alendronate Sodium | 36 | $370 |
| Escitalopram Oxalate | 32 | $335 |
| Metformin Hcl | 30 | $331 |
| Rosuvastatin Calcium | 16 | $293 |
| Amlodipine Besylate | 56 | $288 |
| Gabapentin | 18 | $282 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Yorba Linda
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.